✦ LIBER ✦

P32 Prognostic parameters in node negative breast cancer receiving adjuvant CMF: Analysis of a randomized trial with emphasis on p53 and HER 2 neu

✍ Scribed by A.C. Hardy-Bessard; A. De Roquancourt; P.H. Cottu; P. De Cremoux; M. Marty; M. Espie

Book ID: 117665469
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 154 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)89250-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic value of HER-2/neu and p53 ex

Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatment

✍ M.A. Climent; M.A. Seguı́; G. Peiró; R. Molina; E. Lerma; B. Ojeda; J.J. López-L 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Decreased immunoreactivity for p27 prote

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status : Results from International Breast Cancer Study Group Trial V

✍ Vito J. Spataro; Heather Litman; Giuseppe Viale; Fausto Maffini; Michele Masullo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclin‐dependent kinase inhibitor p27(Kip1) in patients with early‐stage breast carcinoma and to investigate its relation with clinicopathologic features and other m